Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
Anti-Cancer Drug Design
|
June 7, 2002
Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone
M Weigand, G Hartung, J Roboz, et al.
Journal of Synchrotron Radiation
|
June 26, 2007
A 2 m inelastic X-ray scattering spectrometer at CMC-XOR, Advanced Photon Source
J P Hill, D S Coburn, Y J Kim, et al.
International Journal of Oncology
|
April 30, 2011
Enhanced albumin uptake by rat tumors
A Wunder, G Stehle, H Sinn, et al.
The Journal of Clinical Investigation
|
November 1, 1992
Hepatic uptake of a modified low molecular weight heparin in rats
G Stehle, E A Friedrich, H Sinn, et al.
Alimentary Pharmacology & Therapeutics
|
March 5, 2008
Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus
D H Sinn, J H Kim, S Kim, et al.
Critical Reviews in Oncology/Hematology
|
July 1, 1997
Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexia
G Stehle, H Sinn, A Wunder, et al.
Rheumatology (Oxford, England)
|
June 17, 2004
Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX
C Fiehn, U Müller-Ladner, S Gay, et al.
Anti-Cancer Drugs
|
December 24, 1997
Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats
G Stehle, A Wunder, H Sinn, et al.
The Journal of Surgical Research
|
February 1, 1995
Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in rats
G Stehle, A Wunder, H Sinn, et al.
Science (New York, N.Y.)
|
March 29, 2003
Microscopic dynamics of liquid aluminum oxide
H Sinn, B Glorieux, L Hennet, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
Anti-Cancer Drug Design
|
June 7, 2002
Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone
M Weigand, G Hartung, J Roboz, et al.
Journal of Synchrotron Radiation
|
June 26, 2007
A 2 m inelastic X-ray scattering spectrometer at CMC-XOR, Advanced Photon Source
J P Hill, D S Coburn, Y J Kim, et al.
International Journal of Oncology
|
April 30, 2011
Enhanced albumin uptake by rat tumors
A Wunder, G Stehle, H Sinn, et al.
The Journal of Clinical Investigation
|
November 1, 1992
Hepatic uptake of a modified low molecular weight heparin in rats
G Stehle, E A Friedrich, H Sinn, et al.
Alimentary Pharmacology & Therapeutics
|
March 5, 2008
Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus
D H Sinn, J H Kim, S Kim, et al.
Critical Reviews in Oncology/Hematology
|
July 1, 1997
Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexia
G Stehle, H Sinn, A Wunder, et al.
Rheumatology (Oxford, England)
|
June 17, 2004
Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX
C Fiehn, U Müller-Ladner, S Gay, et al.
Anti-Cancer Drugs
|
December 24, 1997
Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats
G Stehle, A Wunder, H Sinn, et al.
The Journal of Surgical Research
|
February 1, 1995
Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in rats
G Stehle, A Wunder, H Sinn, et al.
Science (New York, N.Y.)
|
March 29, 2003
Microscopic dynamics of liquid aluminum oxide
H Sinn, B Glorieux, L Hennet, et al.
Page
of 12